IKANRUL
Live / Registered — Registered (as of 14 Sept 2021)
What this means for you
Registered since 14 Sept 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 14 Sept 2027, and its filing window is open now).
Record
- Serial number
- 79305014
- Registration number
- 6481243
- Mark type
- Word mark
- Filed
- 01 Dec 2020
- Published for opposition
- 29 Jun 2021
- Registered
- 14 Sept 2021
- Next maintenance filing
- §71 affidavit of use, due by 14 Sept 2027 (grace period to 14 Mar 2028)
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
Owner
Prosecution history
- 14 Sept 2026 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 09 Jul 2026 — CORRECTION TRANSACTION RECEIVED FROM IB
- 27 Mar 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 Mar 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Mar 2022 — FINAL DISPOSITION PROCESSED
- 14 Dec 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Oct 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 22 Oct 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Oct 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Sept 2021 — REGISTERED-PRINCIPAL REGISTER
- 29 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jun 2021 — PUBLISHED FOR OPPOSITION
- 09 Jun 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2021 — REFUSAL PROCESSED BY IB